On Monday, Marker Therapeutics Inc (NASDAQ: MRKR) opened higher 16.23% from the last session, before settling in for the closing price of $1.54. Price fluctuations for MRKR have ranged from $0.81 to $4.07 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 23.96%. Company’s average yearly earnings per share was noted 27.01% at the time writing. With a float of $13.53 million, this company’s outstanding shares have now reached $16.67 million.
Marker Therapeutics Inc (MRKR) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Marker Therapeutics Inc is 18.83%, while institutional ownership is 7.85%.
Marker Therapeutics Inc (MRKR) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.42 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.22) by -0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.28% during the next five years compared to 23.96% growth over the previous five years of trading.
Marker Therapeutics Inc (NASDAQ: MRKR) Trading Performance Indicators
Check out the current performance indicators for Marker Therapeutics Inc (MRKR). In the past quarter, the stock posted a quick ratio of 6.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.23, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of Marker Therapeutics Inc (MRKR)
Looking closely at Marker Therapeutics Inc (NASDAQ: MRKR), its last 5-days average volume was 0.34 million, which is a drop from its year-to-date volume of 0.44 million. As of the previous 9 days, the stock’s Stochastic %D was 89.88%.
During the past 100 days, Marker Therapeutics Inc’s (MRKR) raw stochastic average was set at 99.49%, which indicates a significant increase from 99.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1084 in the past 14 days, which was higher than the 0.0826 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1901, while its 200-day Moving Average is $1.2220. However, in the short run, Marker Therapeutics Inc’s stock first resistance to watch stands at $1.8600. Second resistance stands at $1.9300. The third major resistance level sits at $2.0650. If the price goes on to break the first support level at $1.6550, it is likely to go to the next support level at $1.5200. Now, if the price goes above the second support level, the third support stands at $1.4500.
Marker Therapeutics Inc (NASDAQ: MRKR) Key Stats
There are currently 16,673K shares outstanding in the company with a market cap of 29.85 million. Presently, the company’s annual sales total 6,590 K according to its annual income of -10,730 K. Last quarter, the company’s sales amounted to 1,230 K and its income totaled -2,000 K.
